EUVIMEDEUVIMED entdecken
Crossref

Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis

Yueh-Te Lin, Long-Bin Jeng, Fu-Ying Shih, Chiao-Fang Teng iD

Liver International · 2026-04 · 46 (4)

DOI: 10.1111/liv.70582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 08.03.2026. Verfasst von Yueh-Te Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genome Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: China Medical University, Taiwan, National Science and Technology Council, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Discovery of therapeutic targets for hepatocellular carcinoma (HCC) is urgently needed. As an important hepatitis B virus (HBV) oncoprotein, pre‐S2 mutant activates multiple signalling pathways to induce HCC development.

Methods

This study investigated the effect of pre‐S2 mutant on regulating microRNA (miRNA) expression and the role of miRNAs in mediating pre‐S2 mutant's oncogenic functions.

Results

The results showed that 9 miRNAs were downregulated in both tumour tissues of pre‐S2 mutant‐positive HCC patients and pre‐S2 mutant‐expressed human HCC cell lines, contributing to pre‐S2 mutant‐promoted cell proliferation, anchorage‐independent cell growth, cell cycle progression, and tumour growth and malignancy. Moreover, pre‐S2 mutant downregulated miRNA expression at the epigenetic levels through suppression of lysine acetyltransferase 3B (KAT3B)‐ and KAT5‐mediated histone H3 lysine 9 acetylation (H3K9ac) and H4K5ac modifications. The decreased levels of pre‐S2 mutant‐dysregulated miRNAs could also be detected in blood exosomes of patients.

Conclusions

Collectively, this study provided new mechanistic insights and therapeutic perspectives for pre‐S2 mutant‐associated HCC tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, HepatocellularLiver NeoplasmsEpigenesis, GeneticHepatitis B virusHepatitis B Surface AntigensHumansGene Expression Regulation, NeoplasticMutationCell ProliferationAnimalsCell Line, TumorDown-RegulationCarcinogenesisMiceHistonesProtein Precursors

Stichwörter der Autor:innen

epigenetic modificationhepatitis B virushepatocellular carcinomamicroRNApre‐S2 mutant

Substanzen

MicroRNAspresurface protein 2, hepatitis B surface antigenHepatitis B Surface AntigensHistonesProtein Precursors

Autor:innen und Institutionen

  • Cancer Genome Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
  • Department of Surgery, China Medical University Hospital, Taichung, Taiwan.
  • Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, China Medical University, Taichung, Taiwan.
  • Ph.D. Program for Biotech Pharmaceutical Industry, China Medical University, Taichung, Taiwan.

ORCID-Profile: Chiao-Fang Teng

Förderung

  • China Medical University, Taiwan
  • National Science and Technology Council
  • Chang Gung Memorial Hospital

Zitieren

APA

Lin, Y. T., Jeng, L. B., Shih, F. Y., & Teng, C. F. (2026). Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis. Liver International, 46(4). https://doi.org/10.1111/liv.70582

Vancouver

Lin YT, Jeng LB, Shih FY, Teng CF. Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis. Liver International. 2026;46(4). doi:10.1111/liv.70582

BibTeX
@article{Lin2026,
  author = {Lin, Yueh-Te and Jeng, Long-Bin and Shih, Fu-Ying and Teng, Chiao-Fang},
  title = {Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1111/liv.70582}
}
Kostenlos starten →